Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group

O. Schnell, E. Standl, D. Catrinoiu, S. Genovese, N. Lalic, K. Lalic, J. Skrha, P. Valensi, A. Ceriello,

. 2018 ; 17 (1) : 30. [pub] 20180219

Language English Country England, Great Britain

Document type Congress

The 3rd Cardiovascular Outcome Trial Summit of the Diabetes & Cardiovascular Disease EASD Study Group was held on the 26-27 October 2017 in Munich. As in 2015 and 2016, this summit was organised in light of recently completed and published CVOTs on diabetes, aiming to serve as a reference meeting for in-depth discussions on the topic. Amongst others, the CVOTs EXSCEL, DEVOTE, the CANVAS program and the ACE-trial, which released primary outcome results in 2017, were discussed. Trial implications for diabetes management and recent perspectives of diabetologists, cardiologists, endocrinologists, nephrologists and general practitioners were highlighted. The clinical relevance of cardiovascular outcome trials and its implications regarding reimbursement were compared with real-world studies. The 4th Cardiovascular Outcome Trial Summit will be held in Munich 25-26 October 2018 ( http://www.dcvd.org ).

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012823
003      
CZ-PrNML
005      
20190411094644.0
007      
ta
008      
190405s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12933-018-0667-2 $2 doi
035    __
$a (PubMed)29458368
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Schnell, Oliver $u Forschergruppe Diabetes e.V., Munich, Ingolstaedter Landstrasse 1, Neuherberg, 85764, Munich, Germany. oliver.schnell@lrz.uni-muenchen.de.
245    10
$a Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group / $c O. Schnell, E. Standl, D. Catrinoiu, S. Genovese, N. Lalic, K. Lalic, J. Skrha, P. Valensi, A. Ceriello,
520    9_
$a The 3rd Cardiovascular Outcome Trial Summit of the Diabetes & Cardiovascular Disease EASD Study Group was held on the 26-27 October 2017 in Munich. As in 2015 and 2016, this summit was organised in light of recently completed and published CVOTs on diabetes, aiming to serve as a reference meeting for in-depth discussions on the topic. Amongst others, the CVOTs EXSCEL, DEVOTE, the CANVAS program and the ACE-trial, which released primary outcome results in 2017, were discussed. Trial implications for diabetes management and recent perspectives of diabetologists, cardiologists, endocrinologists, nephrologists and general practitioners were highlighted. The clinical relevance of cardiovascular outcome trials and its implications regarding reimbursement were compared with real-world studies. The 4th Cardiovascular Outcome Trial Summit will be held in Munich 25-26 October 2018 ( http://www.dcvd.org ).
650    _2
$a biomedicínský výzkum $x metody $7 D035843
650    _2
$a kardiologie $x metody $7 D002309
650    _2
$a kardiovaskulární nemoci $x diagnóza $x epidemiologie $x terapie $7 D002318
650    12
$a klinické zkoušky jako téma $7 D002986
650    _2
$a kooperační chování $7 D003299
650    _2
$a diabetes mellitus $x diagnóza $x epidemiologie $x terapie $7 D003920
650    _2
$a lidé $7 D006801
650    _2
$a mezioborová komunikace $7 D033183
650    _2
$a týmová péče o pacienty $7 D010348
655    _2
$a kongresy $7 D016423
700    1_
$a Standl, Eberhard $u Forschergruppe Diabetes e.V., Munich, Ingolstaedter Landstrasse 1, Neuherberg, 85764, Munich, Germany.
700    1_
$a Catrinoiu, Doina $u Internal Medicine Department, Clinical County Emergency Hospital Constanta, Tomis Blvd. No. 145, 900591, Constanta, Romania.
700    1_
$a Genovese, Stefano $u Diabetes, Endocrine and Metabolic Disease Unit, IRCCS Centro Cardiologico Monzino, Via Carlo Parea 4, 20138, Milan, Italy.
700    1_
$a Lalic, Nebojsa $u Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Dr Subotica 13, Belgrade, 11000, Serbia.
700    1_
$a Lalic, Katarina $u Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Dr Subotica 13, Belgrade, 11000, Serbia.
700    1_
$a Skrha, Jan $u 3rd Department of Internal Medicine, Charles University, 1st Faculty of Medicine, U Nemocnice 1, Prague 2, 128 08, Czech Republic.
700    1_
$a Valensi, Paul $u Department of Endocrinology Diabetology Nutrition, Paris 13 University, CINFO, CRNH-IdF, Jean VERDIER Hospital, Avenue du 14 Juillet, 93140, Bondy, France.
700    1_
$a Ceriello, Antonio $u Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomedica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain. Department of Cardiovascular and Metabolic Diseases, IRCCS MultiMedica, Via Milanese 300, 20099, Sesto San Giovanni, MI, Italy.
773    0_
$w MED00008211 $t Cardiovascular diabetology $x 1475-2840 $g Roč. 17, č. 1 (2018), s. 30
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29458368 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190411094701 $b ABA008
999    __
$a ok $b bmc $g 1392133 $s 1051128
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 17 $c 1 $d 30 $e 20180219 $i 1475-2840 $m Cardiovascular diabetology $n Cardiovasc Diabetol $x MED00008211
LZP    __
$a Pubmed-20190405

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...